USA - November 20 2020
On November 2, 2020, the Securities and Exchange Commission (SEC) voted to amend the framework for exempt offerings under the Securities Act of 1933…
Mark J. Mihanovic, Robert H. Cohen, Thomas P. Conaghan, Ze’-ev D. Eiger.
USA - August 27 2020
On August 26, 2020, the US Securities and Exchange Commission (the SEC or “Commission”) adopted amendments to the definition of “accredited investor”…
Diana Douglas, Eric Orsic, Heidi Steele, Mark J. Mihanovic, Mark S. Selinger, Robert H. Cohen, Thomas P. Conaghan, Ze’-ev D. Eiger.
USA - July 1 2020
On June 23, 2020, the Division of Corporation Finance (CF) and the Office of the Chief Accountant of the US Securities and Exchange Commission (SEC)…
Eric Orsic, Heidi Steele, Mark J. Mihanovic, Patrick F. Healy, Richard Bass, Robert H. Cohen, Thomas P. Conaghan, Ze’-ev D. Eiger.
USA - October 17 2019
On September 6, 2019, the Staff of the Division of Corporation Finance of the US Securities and Exchange Commission (SEC) announced two major changes…
Daniel L. Woodard, Eric Orsic, Heidi Steele, Mark J. Mihanovic, Robert H. Cohen, Thomas J. Murphy, Thomas P. Conaghan, William Hadler.
USA - September 4 2019
On August 20, 2019, the US Securities and Exchange Commission (SEC) charged TherapeuticsMD Inc., a Boca Raton, Florida, headquartered life sciences…
Eric Orsic, Mark S. Selinger, Thomas P. Conaghan.